The global Retroviral Vectors market was valued at 376 million in 2023 and is projected to reach US$ 758 million by 2030, at a CAGR of 9.5% during the forecast period.
Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow.
The U.S. market is estimated at $ million in 2023, while China is to reach $ million.
Research / Preclinical Grade segment will reach $ million by 2030, with a % CAGR in next six years.
The global key players of Retroviral Vectors include Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, AGC Inc. Group (AGC Biologics), Thermo Fisher Scientific Inc., Creative Biogene, CD Bioparticles, Charles River Laboratories, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retroviral Vectors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Retroviral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retroviral Vectors. This report contains market size and forecasts of Retroviral Vectors in global, including the following market information:
Global Retroviral Vectors market revenue, 2019-2024, 2025-2030, ($ millions)
Global top five Retroviral Vectors companies in 2023 (%)
Total Market by Segment:
Global Retroviral Vectors market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Retroviral Vectors market segment percentages, by Type, 2023 (%)
Research / Preclinical Grade
Clinical Grade
Commercial Grade
Global Retroviral Vectors market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Retroviral Vectors market segment percentages, by Application, 2023 (%)
Gene Therapy
Vaccine Development
Cell Therapy
Global Retroviral Vectors market, by region and country, 2019-2024, 2025-2030 ($ millions)
Global Retroviral Vectors market segment percentages, by region and country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retroviral Vectors revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Retroviral Vectors revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Biovian
Esco Lifesciences Group
ABL, Inc.
Genezen
AGC Inc. Group (AGC Biologics)
Thermo Fisher Scientific Inc.
Creative Biogene
CD Bioparticles
Charles River Laboratories
Avid Bioservices, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retroviral Vectors, market overview.
Chapter 2: Global Retroviral Vectors market size in revenue.
Chapter 3: Detailed analysis of Retroviral Vectors company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retroviral Vectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Retroviral Vectors Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Retroviral Vectors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retroviral Vectors Overall Market Size
2.1 Global Retroviral Vectors Market Size: 2023 VS 2030
2.2 Global Retroviral Vectors Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retroviral Vectors Players in Global Market
3.2 Top Global Retroviral Vectors Companies Ranked by Revenue
3.3 Global Retroviral Vectors Revenue by Companies
3.4 Top 3 and Top 5 Retroviral Vectors Companies in Global Market, by Revenue in 2023
3.5 Global Companies Retroviral Vectors Product Type
3.6 Tier 1, Tier 2, and Tier 3 Retroviral Vectors Players in Global Market
3.6.1 List of Global Tier 1 Retroviral Vectors Companies
3.6.2 List of Global Tier 2 and Tier 3 Retroviral Vectors Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Retroviral Vectors Market Size Markets, 2023 & 2030
4.1.2 Research / Preclinical Grade
4.1.3 Clinical Grade
4.1.4 Commercial Grade
4.2 Segmentation by Type - Global Retroviral Vectors Revenue & Forecasts
4.2.1 Segmentation by Type - Global Retroviral Vectors Revenue, 2019-2024
4.2.2 Segmentation by Type - Global Retroviral Vectors Revenue, 2025-2030
4.2.3 Segmentation by Type - Global Retroviral Vectors Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Retroviral Vectors Market Size, 2023 & 2030
5.1.2 Gene Therapy
5.1.3 Vaccine Development
5.1.4 Cell Therapy
5.2 Segmentation by Application - Global Retroviral Vectors Revenue & Forecasts
5.2.1 Segmentation by Application - Global Retroviral Vectors Revenue, 2019-2024
5.2.2 Segmentation by Application - Global Retroviral Vectors Revenue, 2025-2030
5.2.3 Segmentation by Application - Global Retroviral Vectors Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Retroviral Vectors Market Size, 2023 & 2030
6.2 By Region - Global Retroviral Vectors Revenue & Forecasts
6.2.1 By Region - Global Retroviral Vectors Revenue, 2019-2024
6.2.2 By Region - Global Retroviral Vectors Revenue, 2025-2030
6.2.3 By Region - Global Retroviral Vectors Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Retroviral Vectors Revenue, 2019-2030
6.3.2 United States Retroviral Vectors Market Size, 2019-2030
6.3.3 Canada Retroviral Vectors Market Size, 2019-2030
6.3.4 Mexico Retroviral Vectors Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Retroviral Vectors Revenue, 2019-2030
6.4.2 Germany Retroviral Vectors Market Size, 2019-2030
6.4.3 France Retroviral Vectors Market Size, 2019-2030
6.4.4 U.K. Retroviral Vectors Market Size, 2019-2030
6.4.5 Italy Retroviral Vectors Market Size, 2019-2030
6.4.6 Russia Retroviral Vectors Market Size, 2019-2030
6.4.7 Nordic Countries Retroviral Vectors Market Size, 2019-2030
6.4.8 Benelux Retroviral Vectors Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Retroviral Vectors Revenue, 2019-2030
6.5.2 China Retroviral Vectors Market Size, 2019-2030
6.5.3 Japan Retroviral Vectors Market Size, 2019-2030
6.5.4 South Korea Retroviral Vectors Market Size, 2019-2030
6.5.5 Southeast Asia Retroviral Vectors Market Size, 2019-2030
6.5.6 India Retroviral Vectors Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Retroviral Vectors Revenue, 2019-2030
6.6.2 Brazil Retroviral Vectors Market Size, 2019-2030
6.6.3 Argentina Retroviral Vectors Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retroviral Vectors Revenue, 2019-2030
6.7.2 Turkey Retroviral Vectors Market Size, 2019-2030
6.7.3 Israel Retroviral Vectors Market Size, 2019-2030
6.7.4 Saudi Arabia Retroviral Vectors Market Size, 2019-2030
6.7.5 UAE Retroviral Vectors Market Size, 2019-2030
7 Companies Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Corporate Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Retroviral Vectors Major Product Offerings
7.1.4 Merck KGaA Retroviral Vectors Revenue in Global Market (2019-2024)
7.1.5 Merck KGaA Key News & Latest Developments
7.2 Biovian
7.2.1 Biovian Corporate Summary
7.2.2 Biovian Business Overview
7.2.3 Biovian Retroviral Vectors Major Product Offerings
7.2.4 Biovian Retroviral Vectors Revenue in Global Market (2019-2024)
7.2.5 Biovian Key News & Latest Developments
7.3 Esco Lifesciences Group
7.3.1 Esco Lifesciences Group Corporate Summary
7.3.2 Esco Lifesciences Group Business Overview
7.3.3 Esco Lifesciences Group Retroviral Vectors Major Product Offerings
7.3.4 Esco Lifesciences Group Retroviral Vectors Revenue in Global Market (2019-2024)
7.3.5 Esco Lifesciences Group Key News & Latest Developments
7.4 ABL, Inc.
7.4.1 ABL, Inc. Corporate Summary
7.4.2 ABL, Inc. Business Overview
7.4.3 ABL, Inc. Retroviral Vectors Major Product Offerings
7.4.4 ABL, Inc. Retroviral Vectors Revenue in Global Market (2019-2024)
7.4.5 ABL, Inc. Key News & Latest Developments
7.5 Genezen
7.5.1 Genezen Corporate Summary
7.5.2 Genezen Business Overview
7.5.3 Genezen Retroviral Vectors Major Product Offerings
7.5.4 Genezen Retroviral Vectors Revenue in Global Market (2019-2024)
7.5.5 Genezen Key News & Latest Developments
7.6 AGC Inc. Group (AGC Biologics)
7.6.1 AGC Inc. Group (AGC Biologics) Corporate Summary
7.6.2 AGC Inc. Group (AGC Biologics) Business Overview
7.6.3 AGC Inc. Group (AGC Biologics) Retroviral Vectors Major Product Offerings
7.6.4 AGC Inc. Group (AGC Biologics) Retroviral Vectors Revenue in Global Market (2019-2024)
7.6.5 AGC Inc. Group (AGC Biologics) Key News & Latest Developments
7.7 Thermo Fisher Scientific Inc.
7.7.1 Thermo Fisher Scientific Inc. Corporate Summary
7.7.2 Thermo Fisher Scientific Inc. Business Overview
7.7.3 Thermo Fisher Scientific Inc. Retroviral Vectors Major Product Offerings
7.7.4 Thermo Fisher Scientific Inc. Retroviral Vectors Revenue in Global Market (2019-2024)
7.7.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.8 Creative Biogene
7.8.1 Creative Biogene Corporate Summary
7.8.2 Creative Biogene Business Overview
7.8.3 Creative Biogene Retroviral Vectors Major Product Offerings
7.8.4 Creative Biogene Retroviral Vectors Revenue in Global Market (2019-2024)
7.8.5 Creative Biogene Key News & Latest Developments
7.9 CD Bioparticles
7.9.1 CD Bioparticles Corporate Summary
7.9.2 CD Bioparticles Business Overview
7.9.3 CD Bioparticles Retroviral Vectors Major Product Offerings
7.9.4 CD Bioparticles Retroviral Vectors Revenue in Global Market (2019-2024)
7.9.5 CD Bioparticles Key News & Latest Developments
7.10 Charles River Laboratories
7.10.1 Charles River Laboratories Corporate Summary
7.10.2 Charles River Laboratories Business Overview
7.10.3 Charles River Laboratories Retroviral Vectors Major Product Offerings
7.10.4 Charles River Laboratories Retroviral Vectors Revenue in Global Market (2019-2024)
7.10.5 Charles River Laboratories Key News & Latest Developments
7.11 Avid Bioservices, Inc.
7.11.1 Avid Bioservices, Inc. Corporate Summary
7.11.2 Avid Bioservices, Inc. Business Overview
7.11.3 Avid Bioservices, Inc. Retroviral Vectors Major Product Offerings
7.11.4 Avid Bioservices, Inc. Retroviral Vectors Revenue in Global Market (2019-2024)
7.11.5 Avid Bioservices, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Retroviral Vectors Market Opportunities & Trends in Global Market
Table 2. Retroviral Vectors Market Drivers in Global Market
Table 3. Retroviral Vectors Market Restraints in Global Market
Table 4. Key Players of Retroviral Vectors in Global Market
Table 5. Top Retroviral Vectors Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Retroviral Vectors Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Retroviral Vectors Revenue Share by Companies, 2019-2024
Table 8. Global Companies Retroviral Vectors Product Type
Table 9. List of Global Tier 1 Retroviral Vectors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retroviral Vectors Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. Segmentation by Type – Global Retroviral Vectors Revenue, (US$, Mn), 2023 & 2030
Table 12. Segmentation by Type - Global Retroviral Vectors Revenue (US$, Mn), 2019-2024
Table 13. Segmentation by Type - Global Retroviral Vectors Revenue (US$, Mn), 2025-2030
Table 14. Segmentation by Application– Global Retroviral Vectors Revenue, (US$, Mn), 2023 & 2030
Table 15. Segmentation by Application - Global Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 16. Segmentation by Application - Global Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 17. By Region– Global Retroviral Vectors Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 19. By Region - Global Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 20. By Country - North America Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Retroviral Vectors Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Retroviral Vectors Revenue, (US$, Mn), 2025-2030
Table 30. Merck KGaA Corporate Summary
Table 31. Merck KGaA Retroviral Vectors Product Offerings
Table 32. Merck KGaA Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 33. Merck KGaA Key News & Latest Developments
Table 34. Biovian Corporate Summary
Table 35. Biovian Retroviral Vectors Product Offerings
Table 36. Biovian Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 37. Biovian Key News & Latest Developments
Table 38. Esco Lifesciences Group Corporate Summary
Table 39. Esco Lifesciences Group Retroviral Vectors Product Offerings
Table 40. Esco Lifesciences Group Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 41. Esco Lifesciences Group Key News & Latest Developments
Table 42. ABL, Inc. Corporate Summary
Table 43. ABL, Inc. Retroviral Vectors Product Offerings
Table 44. ABL, Inc. Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 45. ABL, Inc. Key News & Latest Developments
Table 46. Genezen Corporate Summary
Table 47. Genezen Retroviral Vectors Product Offerings
Table 48. Genezen Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 49. Genezen Key News & Latest Developments
Table 50. AGC Inc. Group (AGC Biologics) Corporate Summary
Table 51. AGC Inc. Group (AGC Biologics) Retroviral Vectors Product Offerings
Table 52. AGC Inc. Group (AGC Biologics) Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 53. AGC Inc. Group (AGC Biologics) Key News & Latest Developments
Table 54. Thermo Fisher Scientific Inc. Corporate Summary
Table 55. Thermo Fisher Scientific Inc. Retroviral Vectors Product Offerings
Table 56. Thermo Fisher Scientific Inc. Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 57. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 58. Creative Biogene Corporate Summary
Table 59. Creative Biogene Retroviral Vectors Product Offerings
Table 60. Creative Biogene Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 61. Creative Biogene Key News & Latest Developments
Table 62. CD Bioparticles Corporate Summary
Table 63. CD Bioparticles Retroviral Vectors Product Offerings
Table 64. CD Bioparticles Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 65. CD Bioparticles Key News & Latest Developments
Table 66. Charles River Laboratories Corporate Summary
Table 67. Charles River Laboratories Retroviral Vectors Product Offerings
Table 68. Charles River Laboratories Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 69. Charles River Laboratories Key News & Latest Developments
Table 70. Avid Bioservices, Inc. Corporate Summary
Table 71. Avid Bioservices, Inc. Retroviral Vectors Product Offerings
Table 72. Avid Bioservices, Inc. Retroviral Vectors Revenue (US$, Mn) & (2019-2024)
Table 73. Avid Bioservices, Inc. Key News & Latest Developments
List of Figures
Figure 1. Retroviral Vectors Product Picture
Figure 2. Retroviral Vectors Segment by Type in 2023
Figure 3. Retroviral Vectors Segment by Application in 2023
Figure 4. Global Retroviral Vectors Market Overview: 2022
Figure 5. Key Caveats
Figure 6. Global Retroviral Vectors Market Size: 2023 VS 2030 (US$, Mn)
Figure 7. Global Retroviral Vectors Revenue: 2019-2030 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Retroviral Vectors Revenue in 2023
Figure 9. Segmentation by Type – Global Retroviral Vectors Revenue, (US$, Mn), 2023 & 2030
Figure 10. Segmentation by Type - Global Retroviral Vectors Revenue Market Share, 2019-2030
Figure 11. Segmentation by Application – Global Retroviral Vectors Revenue, (US$, Mn), 2023 & 2030
Figure 12. Segmentation by Application - Global Retroviral Vectors Revenue Market Share, 2019-2030
Figure 13. By Region - Global Retroviral Vectors Revenue Market Share, 2019-2030
Figure 14. By Country - North America Retroviral Vectors Revenue Market Share, 2019-2030
Figure 15. United States Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 16. Canada Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 17. Mexico Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 18. By Country - Europe Retroviral Vectors Revenue Market Share, 2019-2030
Figure 19. Germany Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 20. France Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 21. U.K. Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 22. Italy Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 23. Russia Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 24. Nordic Countries Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 25. Benelux Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 26. By Region - Asia Retroviral Vectors Revenue Market Share, 2019-2030
Figure 27. China Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 28. Japan Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 29. South Korea Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 30. Southeast Asia Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 31. India Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 32. By Country - South America Retroviral Vectors Revenue Market Share, 2019-2030
Figure 33. Brazil Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 34. Argentina Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 35. By Country - Middle East & Africa Retroviral Vectors Revenue Market Share, 2019-2030
Figure 36. Turkey Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 37. Israel Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 38. Saudi Arabia Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 39. UAE Retroviral Vectors Revenue, (US$, Mn), 2019-2030
Figure 40. Merck KGaA Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 41. Biovian Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Esco Lifesciences Group Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. ABL, Inc. Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Genezen Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AGC Inc. Group (AGC Biologics) Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Thermo Fisher Scientific Inc. Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Creative Biogene Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. CD Bioparticles Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Charles River Laboratories Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Avid Bioservices, Inc. Retroviral Vectors Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
